The 5Ad Diet for Functional Bowel Disorders

Last updated: November 21, 2025
Sponsor: University of Suffolk
Overall Status: Completed

Phase

N/A

Condition

Irritable Bowel Syndrome (Ibs- Pediatric)

Gastrointestinal Diseases And Disorders

Lactose Intolerance

Treatment

The 5Ad Diet

The Low FODMAP Diet

Clinical Study ID

NCT06338189
USuffolk
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this randomised controlled trial (RCT) is to compare the efficacy of the newly developed 5Ad diet against the widely researched low fermentable oligo-, di-, monosaccharide and polyols (FODMAP) diet in reducing gastrointestinal symptoms associated with functional bowel disorders/food intolerances.

The primary aims of this RCT are to determine:

  • Whether the 5Ad diet is at least as effective as the low FODMAP diet in reducing gastrointestinal symptoms associated with FBDs/food intolerances.

  • Whether either the 5Ad diet or the low FODMAP diet are effective in reducing mental and physical fatigue.

To achieve the above aims, an RCT will be conducted with the 5Ad diet in one arm vs the active phase of the low FODMAP diet in the other arm, in a cross-over design with a 7 days washout phase in between. Both dietary protocols will be followed by each participant for 7 days.

Researchers will compare the results from the 2 dietary protocols in order to ascertain the superiority of one over the other in regards to 6 gastrointestinal symptoms (abdominal pain, bloating, flatulence, bowel urgency, straining and incomplete defecation), stool form and frequency of defecation.

Eligibility Criteria

Inclusion

Inclusion Criteria:

Individuals are eligible for the study if all of the following criteria are met:

  • Suffers chronically from either constipation, diarrhoea, or an alternation of both,bloating, flatulence or abdominal pain, incomplete defecation, straining and bowelurgency.

  • Symptoms must be present for ≥ 2 times per week, with symptom onset occurring atleast 3 months prior to participation.

  • Participants taking prescribed medications which may affect bowel function areincluded only if the intake is maintained throughout the entire intervention period.

Exclusion

Exclusion Criteria:

Individuals are excluded from the study if any of the following criteria are met:

  • Pregnant.

  • Known underlying pathology (e.g., Crohn's disease, ulcerative colitis, celiacdisease).

  • History of abdominal/gastrointestinal surgery within 1 year prior to participation.

  • History of antibiotic use in the last 6 weeks prior to participation.

  • Allergic to the foods specified in both the 5Ad diet and the low FODMAP diet.

Study Design

Total Participants: 52
Treatment Group(s): 2
Primary Treatment: The 5Ad Diet
Phase:
Study Start date:
May 08, 2022
Estimated Completion Date:
April 01, 2025

Study Description

Functional Bowel Disorders (FBDs) are characterised by chronic gastrointestinal symptoms including abdominal pain, constipation, bloating, diarrhoea, alternating abdominal symptoms, and irregular frequency of bowel movements among others in the absence of any intestinal abnormality. The prevalence of FBDs ranges from 15 - 20% worldwide, with remarkable economic burden on health systems and significant impact on the quality of life of sufferers. It is estimated that between 60% - 89% of individuals that suffer from FBDs find that foods exacerbate their symptoms. Therefore, dietary therapies are frequently implemented to assist with symptom relief in these individuals.

Although the low FODMAP diet is the most commonly followed diet for the treatment of FBDs, there are concerns regarding it's complexity, restrictiveness, nutritional adequacy, and effectiveness. Therefore, the 5Ad diet was designed to fill a gap in the existing research and to overcome the limitations associated with existing dietary approaches.

Preliminary findings from the first study in 2019 suggested that the 5Ad diet might be a promising universal approach for varying forms and severities of FBDs. Therefore, an RCT is needed to substantiate these previous results. Thus, this RCT aims to determine whether the 5Ad diet is at least as effective as the low FODMAP diet in reducing gastrointestinal symptoms associated with FBDs/food intolerances.

Connect with a study center

  • University of Suffolk

    Ipswich, Suffolk IP4 1QJ
    United Kingdom

    Site Not Available

  • University of Suffolk

    Ipswich 2646057, Suffolk IP4 1QJ
    United Kingdom

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.